Five Star Equities releases regular market updates so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at www.FiveStarEquities.com and get exclusive access to our numerous stock reports.
Acura Pharmaceuticals, Inc. (NASDAQ: ACUR) shares fell 7.61 percent to close at $1.82 a share Monday. The stock traded between $1.72 and $1.92 on volume of 1.38 million shares traded. The company reported a net loss of $3.4 million for the fourth quarter of 2013, up from $3.0 million a year ago. Shares of Acura Pharmaceuticals are up approximately 9.0 percent year-to-date.
Get more information on Acura Pharmaceuticals and free access to the in-depth equity report at: www.FiveStarEquities.com/ACUR
Atossa Genetics Inc. (NASDAQ: ATOS) shares dropped 11.32 percent to close at $1.88 a share Monday. The stock traded between $1.75 and $1.90 on volume of 2.76 million shares traded. The company announced that the FDA has requested additional information related to its 510(k) application for the ForeCYTE Breast Aspirator. Shares of Atossa Genetics are down approximately 20.0 percent year-to-date.
Get more information on Atossa Genetics and free access to the in-depth equity report at: www.FiveStarEquities.com/ATOS
AuRico Gold Inc. (NYSE: AUQ) shares declined 4.62 percent to close at $4.75 a share Tuesday. The stock traded between $4.62 and $4.95 on volume 4.07 million shares traded. The company reported revenues were $50.8 million for the fourth quarter of 2013, a decrease of 19.5 percent when compared to a year ago. Shares of AuRico Gold are up approximately 30.0 percent year-to-date.
Get more information on AuRico Gold free access to the in-depth equity report at: www.FiveStarEquities.com/AUQ
McDermott International (NYSE: MDR) shares declined 8.26 percent to close at $7.44 a share Tuesday. The stock traded between $7.25 and $7.62 on volume 33.03 million shares traded. The company reported revenues were $517.0 million for the fourth quarter of 2013, a decrease of 48.0 percent when compared to a year ago. Shares of McDermott International are down approximately 18.0 percent year-to-date.
Get more information on McDermott International and free access to the in-depth equity report at: www.FiveStarEquities.com/MDR
Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Five Star Equities has no financial relationship with any company whose stock is mentioned in this release.
Contact: Five Star Equities [email protected]